Fortrea Holdings Inc (FTRE)

$14.98 -0.45 (-2.92%)
Market Cap 1.46B
Revenue (ttm) 2.72B
Net Income (ttm) -986.20M
EPS (ttm) N/A
PE Ratio 27.80
Forward PE 20.40
Profit Margin -36.21%
Debt to Equity Ratio 1.87
Volume 813,138
Avg Vol 1,505,506
Day's Range N/A - N/A
Shares Out 94.60M
Stochastic %K 87%
Beta 1.92
Analysts Sell
Price Target $15.75

Company Profile

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 495 0816
Address:
8 Moore Drive, Durham, United States
LewisDaKat
LewisDaKat May. 5 at 7:00 PM
$FTRE Fortrea (FTRE) Q1 2026 Earnings Transcript https://marketwirenews.com/stock/ftre/news/fortrea-ftre-q1-2026-earnings-transcript-4703803164741851.html?utm_source=stocktwits
0 · Reply
STACKD0E
STACKD0E May. 5 at 1:29 PM
$DOCN $FTRE $TLIH
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 10:17 AM
$FTRE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 up 96.00% YoY • Reported revenue of $636.5M down -2.27% YoY • Fortrea reiterated its full year 2026 guidance, targeting revenues between $2.55B and $2.65B, and adjusted EBITDA in the range of $190 million to $220 million.
0 · Reply
anachartanalyst
anachartanalyst Apr. 8 at 4:02 PM
$FTRE https://anachart.com/wp-content/uploads/ana_temp/1775664102_soc-img.jpg
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 24 at 3:05 PM
$FTRE RSI: 42.71, MACD: -0.7493 Vol: 0.57, MA20: 9.83, MA50: 12.69 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RunnerSignals
RunnerSignals Mar. 10 at 8:37 PM
analyst upgrades fuel buying $FTRE $HIMS $TDOC $WING $ACHR all reacted to upgrades today, volume surges show institutional interest, early dips recovered, momentum intact https://stocksrunner.com/news/2026-03-10-top-stock-upgrades-today-in-the-buzz
0 · Reply
IN0V8
IN0V8 Mar. 9 at 3:42 PM
$FTRE TD Cowen raises to buy from hold
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 2 at 11:23 PM
$FTRE Current Stock Price: $10.58 Contracts to trade: $10.0 FTRE Mar 20 2026 Call Entry: $1.10 Exit: $2.20 ROI: 100% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StockScanners
StockScanners Feb. 28 at 7:24 PM
$FTRE reached 11.11
0 · Reply
StockScanners
StockScanners Feb. 27 at 4:38 AM
$FTRE keep watch if this holds above 10.41
0 · Reply
Latest News on FTRE
Fortrea price target raised to $14 from $11 at Deutsche Bank

2026-05-07T20:33:28.000Z - 3 days ago

Fortrea price target raised to $14 from $11 at Deutsche Bank

Fortrea price target raised to $16 from $11 at Barclays

2026-05-07T10:25:14.000Z - 4 days ago

Fortrea price target raised to $16 from $11 at Barclays

Fortrea price target raised to $20 from $15 at Baird

2026-05-07T09:20:20.000Z - 4 days ago

Fortrea price target raised to $20 from $15 at Baird

Fortrea price target raised to $20 from $15 at Baird

2026-05-07T09:19:56.000Z - 4 days ago

Fortrea price target raised to $20 from $15 at Baird

Fortrea price target raised to $20 from $16 at Citi

2026-05-07T08:48:22.000Z - 4 days ago

Fortrea price target raised to $20 from $16 at Citi

Fortrea price target raised to $18 from $15 at TD Cowen

2026-05-07T05:22:58.000Z - 4 days ago

Fortrea price target raised to $18 from $15 at TD Cowen

Fortrea price target raised to $19 from $16 at Truist

2026-05-07T04:22:31.000Z - 4 days ago

Fortrea price target raised to $19 from $16 at Truist

Fortrea Holdings Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 6 days ago

Fortrea Holdings Earnings Call Transcript: Q1 2026

Fortrea Reports First Quarter 2026 Results

May 5, 2026, 6:00 AM EDT - 6 days ago

Fortrea Reports First Quarter 2026 Results

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

Apr 21, 2026, 8:45 AM EDT - 20 days ago

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

Fortrea price target lowered to $11 from $12 at Barclays

2026-04-14T10:48:56.000Z - 27 days ago

Fortrea price target lowered to $11 from $12 at Barclays

Fortrea price target lowered to $14 from $25 at Evercore ISI

2026-04-08T13:21:48.000Z - 4 weeks ago

Fortrea price target lowered to $14 from $25 at Evercore ISI

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Apr 7, 2026, 7:00 AM EDT - 4 weeks ago

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mar 10, 2026, 4:15 PM EDT - 2 months ago

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea upgraded to Buy from Hold at TD Cowen

2026-03-09T10:16:30.000Z - 2 months ago

Fortrea upgraded to Buy from Hold at TD Cowen

Fortrea price target lowered to $14 from $16 at Deutsche Bank

2026-02-27T14:42:51.000Z - 2 months ago

Fortrea price target lowered to $14 from $16 at Deutsche Bank

Fortrea price target lowered to $16 from $19 at Baird

2026-02-27T12:22:38.000Z - 2 months ago

Fortrea price target lowered to $16 from $19 at Baird

Fortrea price target lowered to $16 from $21 at Citi

2026-02-27T11:40:55.000Z - 2 months ago

Fortrea price target lowered to $16 from $21 at Citi

Fortrea price target lowered to $12 from $15 at Barclays

2026-02-27T10:41:23.000Z - 2 months ago

Fortrea price target lowered to $12 from $15 at Barclays

Fortrea Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 2 months ago

Fortrea Holdings Earnings Call Transcript: Q4 2025

Fortrea reports Q4 adjusted EPS 9c, consensus 16c

2026-02-26T11:11:33.000Z - 2 months ago

Fortrea reports Q4 adjusted EPS 9c, consensus 16c

Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Feb 26, 2026, 6:00 AM EST - 2 months ago

Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Fortrea appoints Cohen as CMO, Dove as President of CPS

2026-02-17T12:21:23.000Z - 2 months ago

Fortrea appoints Cohen as CMO, Dove as President of CPS

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

Feb 17, 2026, 7:00 AM EST - 2 months ago

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

CRO peers lower after Medpace earnings, comments on cancellations

2026-02-10T15:10:13.000Z - 3 months ago

CRO peers lower after Medpace earnings, comments on cancellations

CRL ICLR MEDP

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Jan 29, 2026, 8:08 AM EST - 3 months ago

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

Jan 20, 2026, 3:38 PM EST - 3 months ago

Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

Fortrea Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 4 months ago

Fortrea Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

Jan 9, 2026, 11:24 AM EST - 4 months ago

Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference

Jan 6, 2026, 7:00 AM EST - 4 months ago

Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

Dec 4, 2025, 7:00 AM EST - 5 months ago

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

Fortrea Holdings Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 10:50 AM EST - 5 months ago

Fortrea Holdings Transcript: Evercore ISI 8th Annual HealthCONx Conference

Fortrea Holdings Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 1:00 PM EST - 5 months ago

Fortrea Holdings Transcript: Citi Annual Global Healthcare Conference 2025

Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences

Nov 25, 2025, 7:00 AM EST - 5 months ago

Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

Nov 24, 2025, 7:00 AM EST - 6 months ago

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

Fortrea Appoints Agnieszka Gallagher as General Counsel

Nov 17, 2025, 7:00 AM EST - 6 months ago

Fortrea Appoints Agnieszka Gallagher as General Counsel

Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer

Nov 12, 2025, 7:06 AM EST - 6 months ago

Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer

Fortrea Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 6 months ago

Fortrea Holdings Earnings Call Transcript: Q3 2025

Fortrea Reports Third Quarter 2025 Results

Nov 5, 2025, 6:30 AM EST - 6 months ago

Fortrea Reports Third Quarter 2025 Results

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

Oct 15, 2025, 7:00 AM EDT - 7 months ago

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

Fortrea Appoints William Sharbaugh to Board of Directors

Sep 22, 2025, 4:30 PM EDT - 8 months ago

Fortrea Appoints William Sharbaugh to Board of Directors

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

Aug 25, 2025, 9:55 AM EDT - 9 months ago

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

Fortrea Holdings Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 9 months ago

Fortrea Holdings Earnings Call Transcript: Q2 2025

Fortrea Reports Second Quarter 2025 Results

Aug 6, 2025, 6:30 AM EDT - 9 months ago

Fortrea Reports Second Quarter 2025 Results

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

Aug 5, 2025, 6:00 PM EDT - 9 months ago

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE

Jul 31, 2025, 10:39 AM EDT - 10 months ago

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE

FTRE DEADLINE: Lose Money on Fortrea Holdings Inc. (NASDAQ:FTRE)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 1

Jul 22, 2025, 8:36 AM EDT - 10 months ago

FTRE DEADLINE: Lose Money on Fortrea Holdings Inc. (NASDAQ:FTRE)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 1

Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call

Jul 16, 2025, 7:00 AM EDT - 10 months ago

Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call

FTRE COURT NOTICE: Fortrea Holdings Inc. Investors may have been Affected by Fraud – Contact BFA Law by the August 1 Legal Deadline (NASDAQ:FTRE)

Jul 10, 2025, 8:18 AM EDT - 10 months ago

FTRE COURT NOTICE: Fortrea Holdings Inc. Investors may have been Affected by Fraud – Contact BFA Law by the August 1 Legal Deadline (NASDAQ:FTRE)

FTRE INVESTOR DEADLINE: Fortrea Holdings Inc. Investors with Losses may have been Affected by Fraud – Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

Jun 28, 2025, 7:46 AM EDT - 11 months ago

FTRE INVESTOR DEADLINE: Fortrea Holdings Inc. Investors with Losses may have been Affected by Fraud – Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Jun 24, 2025, 7:00 AM EDT - 11 months ago

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

FTRE COURT REMINDER: Fortrea Holdings Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

Jun 20, 2025, 9:07 AM EDT - 11 months ago

FTRE COURT REMINDER: Fortrea Holdings Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

FTRE NOTICE: Did Fortrea Holdings Inc. Mislead Investors? Contact BFA Law by August 1 Court Deadline if You Suffered Losses (NASDAQ:FTRE)

Jun 18, 2025, 8:38 AM EDT - 11 months ago

FTRE NOTICE: Did Fortrea Holdings Inc. Mislead Investors? Contact BFA Law by August 1 Court Deadline if You Suffered Losses (NASDAQ:FTRE)

LewisDaKat
LewisDaKat May. 5 at 7:00 PM
$FTRE Fortrea (FTRE) Q1 2026 Earnings Transcript https://marketwirenews.com/stock/ftre/news/fortrea-ftre-q1-2026-earnings-transcript-4703803164741851.html?utm_source=stocktwits
0 · Reply
STACKD0E
STACKD0E May. 5 at 1:29 PM
$DOCN $FTRE $TLIH
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 10:17 AM
$FTRE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 up 96.00% YoY • Reported revenue of $636.5M down -2.27% YoY • Fortrea reiterated its full year 2026 guidance, targeting revenues between $2.55B and $2.65B, and adjusted EBITDA in the range of $190 million to $220 million.
0 · Reply
anachartanalyst
anachartanalyst Apr. 8 at 4:02 PM
$FTRE https://anachart.com/wp-content/uploads/ana_temp/1775664102_soc-img.jpg
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 24 at 3:05 PM
$FTRE RSI: 42.71, MACD: -0.7493 Vol: 0.57, MA20: 9.83, MA50: 12.69 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RunnerSignals
RunnerSignals Mar. 10 at 8:37 PM
analyst upgrades fuel buying $FTRE $HIMS $TDOC $WING $ACHR all reacted to upgrades today, volume surges show institutional interest, early dips recovered, momentum intact https://stocksrunner.com/news/2026-03-10-top-stock-upgrades-today-in-the-buzz
0 · Reply
IN0V8
IN0V8 Mar. 9 at 3:42 PM
$FTRE TD Cowen raises to buy from hold
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 2 at 11:23 PM
$FTRE Current Stock Price: $10.58 Contracts to trade: $10.0 FTRE Mar 20 2026 Call Entry: $1.10 Exit: $2.20 ROI: 100% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StockScanners
StockScanners Feb. 28 at 7:24 PM
$FTRE reached 11.11
0 · Reply
StockScanners
StockScanners Feb. 27 at 4:38 AM
$FTRE keep watch if this holds above 10.41
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 11:15 AM
$FTRE Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.35 up 48.53% YoY • Reported revenue of $660.5M down -5.24% YoY • For the full year 2026, Fortrea targets revenues in the range of $2.55B to $2.65B and adjusted EBITDA in the range of $190M to $220M.
0 · Reply
buyabdhodler
buyabdhodler Feb. 25 at 12:55 AM
$EVH feel like this is the next $FTRE
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 1:28 PM
$FTRE RSI: 22.83, MACD: -1.6069 Vol: 2.87, MA20: 14.08, MA50: 15.72 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LamontShafer266
LamontShafer266 Feb. 21 at 9:13 AM
$FTRE Fortrea provides CRO services after spin-off. Growth depends on clinical trial demand. Margin normalization is key.
0 · Reply
RunnerSignals
RunnerSignals Feb. 19 at 9:15 PM
Morning Losers Turned Winners $ATOM.X $CGEM $XPRO $CYH $FTRE were down early but pulled off a comeback
0 · Reply
EquityBrief
EquityBrief Feb. 18 at 4:02 PM
$FTRE Fortrea provides clinical trial services. Demand depends on biotech R&D spending. Margin improvement supports long-term outlook.
0 · Reply
FrontierX
FrontierX Feb. 4 at 1:59 PM
$FTRE is a provider of specialized transportation and logistics services; its performance is tied to industrial production and the health of its key customer verticals.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 3:16 PM
$FTRE RSI: 46.55, MACD: 0.3602 Vol: 0.57, MA20: 17.06, MA50: 15.21 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
anachartanalyst
anachartanalyst Jan. 22 at 5:02 PM
$FTRE https://anachart.com/wp-content/uploads/ana_temp/1769101325_soc-img.jpg
0 · Reply
IN0V8
IN0V8 Jan. 8 at 4:55 PM
$FTRE Truist Securities raises target price to $22 from $12 Truist Securities raises to buy from hold
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 30 at 2:32 AM
$FTRE RSI: 75.68, MACD: 1.4900 Vol: 1.63, MA20: 15.73, MA50: 12.79 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 1:14 PM
Mizuho has adjusted their stance on Fortrea Holdings ( $FTRE ), setting the rating to Neutral with a target price of 11 → 13.
0 · Reply